|
|
Leukemia
Frequently Asked Questions
20. What new treatments for leukemia are
being developed? - cont'd
The drug imatinib (Gleevec®) is important in the treatment of
chronic myeloid leukemia. However, imatinib stops working in some
people with leukemia because the cells become resistant.
Fortunately, two drugs, dasatinib (Sprycel®) and nilotinib
(Tasigna®), have been shown to be effective in clinical trials
for the treatment of people who stop responding to imatinib. Both
are approved by the FDA for use in patients. These drugs work
against the same abnormal protein targeted by imatinib, but in
different ways. (Answer continues on next page.)
|
| |
|
|
